News

May 14, 2026

Novel Therapeutic Agent Shows Promise in Rejuvenating Skin and Enhancing Wound Healing

Researchers have identified a breakthrough compound that demonstrates remarkable efficacy in reversing signs of skin aging and accelerating wound healing. This novel therapeutic agent has been found to have potential applications in treating various dermatological conditions.

By: MedExpo Team Read More

May 14, 2026

Enzyme engineering opens door to novel therapies for Parkinson's, cancers and other hard-to

Scripps Research Institute. "Enzyme engineering opens door to novel therapies for Parkinson's, cancers and other hard-to-target protein diseases." ScienceDaily. ScienceDaily, 27 March 2025. <www.sc...

By: MedExpo Team Read More

May 14, 2026

Novel Therapeutic Approaches for Protein Diseases Emerging through Enzyme Engineering

Researchers at the Scripps Research Institute have made significant progress in enzyme engineering, paving the way for innovative treatments for conditions such as Parkinson's disease and certain types of cancer. This breakthrough has opened up new possibilities for targeting protein-based diseases that have long been challenging to treat.

By: MedExpo Team Read More

May 14, 2026

Novel Therapies on the Horizon for Intractable Protein Diseases

Researchers at the Scripps Research Institute have made significant progress in enzyme engineering, a breakthrough that may lead to innovative treatments for Parkinson's disease, certain cancers, and other challenging protein-related disorders. This advance offers new hope for patients who have been resistant to traditional therapies.

By: MedExpo Team Read More

May 14, 2026

Incidence of several early

A recent study has found that the incidence of several early-onset cancers increased between 2010 and 2019. The findings highlight a concerning trend that warrants further investigation.

By: MedExpo Team Read More

May 14, 2026

Gene

Researchers have developed a gene-based blood test that may help identify early signs of melanoma recurrence. This non-invasive test uses genetic markers to detect cancer cells in the bloodstream, potentially improving outcomes for patients with this aggressive form of skin cancer.

By: MedExpo Team Read More

May 14, 2026

Novel Therapies Emerge for Difficult-to-Treat Diseases

Researchers at the Scripps Research Institute have made a breakthrough in enzyme engineering, paving the way for innovative treatments of Parkinson's disease, certain cancers, and other complex protein disorders. This advance holds promise for patients who have not responded to current therapies.

By: MedExpo Team Read More

May 13, 2026

Estrogen Receptors and Disease Treatment

Researchers at the Salk Institute have identified estrogen-related receptors as potential targets for treating metabolic and muscular disorders. These findings suggest a new approach to understanding and addressing various diseases.

By: MedExpo Team Read More

May 13, 2026

Estrogen Receptors in Metabolic and Muscular Disorders

Researchers at the Salk Institute have identified estrogen-related receptors as potential therapeutic targets for treating metabolic and muscular disorders. These findings suggest that manipulating these receptors could lead to new treatments for a range of conditions.

By: MedExpo Team Read More